Ireland - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Ireland Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases grew 40.6% year on year. In 2019, the country was number 248 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 11 Cases. India ranked the highest with 66,255 Cases in 2019, a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 11.00 |
2018 | 9.00 |
2017 | 6.00 |
2016 | 7.00 |
2015 | 1.00 |
Download all data from 2005 to 2019
How does Ireland rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
244 |
#244
Suriname
|
12 | 2019 | -7.7 % | +5.9 % | View data | |
248 |
#248
Ireland
|
11 | 2019 | +22.2 % | +40.6 % | View data | |
248 |
#248
Lebanon
|
11 | 2019 | +175.0 % | +1.9 % | View data |